ArticleLife (Basel, Switzerland)2025

Safety, Pharmacokinetics, and Food Effect of the RORα Agonist TB-840, a Novel Candidate for Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Randomized First-in-Human Study in Healthy Volunteers.

Inyoung Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.